Manufacturer patient assistance programs and copay savings cards can reduce costs for eligible patients, though these programs have specific eligibility criteria and may not be available for government insurance beneficiaries due to federal anti-kickback regulations
It suppresses hunger signals and enhances satiety sensation, fundamentally reducing appetite, curbing binge eating, and decreasing cravings for high-sugar and high-fat foods, thereby actively reducing daily calorie intake
The results demonstrated that the 25mg daily pill delivered clinically meaningful weight loss: Average weight loss of 13.6-16.6% compared to 2.2-2.7% with placebo 76% of participants achieved at least 5% weight loss versus 31% on placebo Over 30% achieved 20% or greater weight loss Significant improvements in blood pressure, cholesterol, and inflammatory markers These results are comparable to what weve seen with injectable Wegovy, which typically produces 12-15% weight loss
The Future of GLP-1 Virtual Clinics The future of virtual clinics in the healthcare industry looks promising, with the potential for further advancements in technology and AI to enhance patient care and improve outcomes
Clinical Significance: These data suggest that orforglipron could provide an oral alternative to injectable GLP-1 therapies